Freenome, Inc. (Nasdaq: FRNM), an early cancer detection company developing blood-based tests, today announced the company will present late-breaking data on an updated version of its SimpleScreen™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results